Abstract
The fibrin matrix is fundamentally formed by the polymerization of fibrinogen and thrombin in blood plasma. It is a natural biopolymeric material to widely investigate for various tissue regenerations due to good biocompatibility, rapid biodegradability, and easy fabrication. In particular, the conjugated bioactive molecules with fibrinogen can promote tissue morphogenesis or maturation after cell adhesion on the matrices, migration, proliferation, or differentiation. Using these physiological properties with cell-material interactions, the fibrin matrices have been utilized in tissue engineering applications such as skin tissue, cardiovascular tissue, musculoskeletal tissue, or nerve tissue in preclinical and clinical situations. This chapter demonstrates the fibrin material and its tissue engineering applications as the therapeutic strategies.
Access provided by CONRICYT-eBooks. Download chapter PDF
Similar content being viewed by others
Keywords
1 Background of Fibrin Biomaterials
1.1 Background with Biology
Fibrin is a fibrillar biopolymer that is naturally formed during blood clotting. Hemostasis is a primary role of fibrin, but fibrin also functions as a provisional matrix during wound healing. Fibrin possess the properties suitable for its use in regenerative medicine; fibrin is capable of conveying matrix proteins such as fibronectin and growth factors (Makogonenko et al. 2002; Rybarczyk et al. 2003; Mosesson 2005; Laurens et al. 2006a, b; Wolberg 2007; Janmey et al. 2009). Given these features, fibrin has been widely studied in biomedical research for its ability to repair hard and soft tissues (Hubbell 2003; Falanga et al. 2007; Ahmed et al. 2008; Breen et al. 2009a, b; Davis et al. 2011; Oh et al. 2014).
The biological functions of fibrin involve its structure. A number of variables can influence the structure of fibrin, including the local pH, ionic strength, and the concentrations of calcium and thrombin (Mosesson 2005; Wolberg 2007). The thrombin concentration present at the time of gelation has important influences on fibrin clot structure. The low thrombin concentrations produce fibrin clots that are turbid and composed of thick, loosely-woven fibrin strands. Higher concentrations of thrombin produce fibrin clots that are composed of relatively thinner, more tightly-packed fibrin strands (Collet et al. 2000; Wolberg 2007). Thrombin exposes the cryptic fibronectin-binding sites in fibrinogen and that fibronectin mostly bound to polymerized fibrin but rarely bound to fibrinogen (Makogonenko et al. 2002) and modulates the fibronectin-binding capacity of fibrin and that this modulation of thrombin contributes to integrin phosphorylation of the cells (Oh et al. 2012). The structure of the fibrin biomaterials affects their biological functions. Thus, it should be optimized for specific applications in tissue engineering and regenerative medicine.
1.2 Biodegradation of Fibrin: Fibrinolysis
The biodegradation process of fibrin material is known as the fibrinolysis or fibrinolytic system, which is mediated by plasmin (Baron and Kneissel 2013; Park et al. 2017). Briefly, fibrin degradation can be catalyzed by cell-surface-associated plasmin, which formed after binding soluble plasminogen and plasminogen activators (tissue-type plasminogen activator; t-pA and urokinase-type plasminogen activator; u-pA). In particular, the lysine-binding domains of plasminogen play an important role in the binding of plasminogen to fibrin for the fibrin degradation. In the inhibition of the fibrinolytic system, the plasminogen activator inhibitor-1 (PAI-1) or α2-antiplasmin (α2Ap) neutralize the plasminogen activators and block the interactions between binding domain of plasminogen and fibrin structures. Therefore, the biochemical interactions with plasminogen, fibrin, and plasminogen activators are contributed for controls of fibrin degradation process (Baron and Kneissel 2013; Park et al. 2017).
2 Tissue Engineering Applications Using Fibrin Biomaterials
At present, various pre-clinical/clinical approaches have been actively developed for regeneration of damaged tissues and wound healings using fibrin-based biomaterials (Table 16.1). In particular, fibrin can be dimensionally modified (two−/three-dimensional scaffolds) or its phasic characteristics (injectable or implantable matrices) can be fabricated to promote biological interactions in optimal tissue regeneration for wound healing and functioning restorations. According to target tissue defects or physiological environments, several therapeutic techniques have been implemented to improve mechanical, physical, chemical, or biological properties (Lee and Kurisawa 2013; Li et al. 2015).
2.1 Skin Tissue Engineering
Skin is the largest organ in the human body and consists of approximately 10% of the whole body weight. It is a crucial barrier between the internal and external with three distinct layers: the epidermis, the dermis, and the hypodermis (or subcutaneous tissue) (Chaudhari et al. 2016; Huang and Fu 2010; MacNeil 2008). The epidermis is the outermost layer to form a highly effective barrier against infectious pathogens from the external environments and maintain appropriate or optimal hydration (Huang and Fu 2010). Although capillary structures are formed under epidermis layer, 95% keratinocyte cells were contained in the epidermis without the vasculature networks. The dermis layer is between the epidermis and the hypodermis with connective tissues which are composed of fibroblasts, macrophages, and adipocytes (Priya et al. 2008). It has the primarily role to generate appropriate stress-strain mechanical responses by matrix components like collagen, elastin, and extrafibrillar matrix (MacNeil 2008). The hypodermis is the lowermost layer and below the dermis of vertebrate skin and has similar cell types to the dermis; fibroblasts, adipose cells, and macrophages. Compared to the dermis, the hypodermis mainly consists of loose connective tissue and subcutaneous fat with large blood vessels and nerves which cannot be found in epidermis and dermis tissues. Therefore, healthy skin tissue has various cell types such as keratinocytes, fibroblasts, or mesenchymal stem cells to regenerate complex tissue constructs and restore their functions (MacNeil 2008).
Fibrin has been utilized to induce skin tissue regeneration as vehicles for bioactive molecules to promote wound healing, delivery carriers for multiple cells like keratinocytes, fibroblast-like cells, and mesenchymal stem cells, or sealants for skin graft fixation to stop the bleeding (Bensaid et al. 2003; Jimenez and Jimenez 2004; Wechselberger et al. 2002).
2.2 Cardiac/Vascular Tissue Engineering
The cardiovascular system is the hemodynamic tissue complex with complicated responsiveness. The major components of the system are heart valves, cardiac muscles and the blood vasculatures, which are significantly challenging to regenerate or heal within the limited golden time. The cardiovascular tissues should have flexible responsiveness against various mechanical stimulations such as pressure, blood shear stress, molecular permeability in dynamic fluidics, and immunological responses (Gebara et al. 1997; Pober and Tellides 2012). In particular, severed ischemic cardiac tissue damages or injuries are irreversible or limitedly viable to restore vital functions (Hasan et al. 2015).
Grassl et al. developed and demonstrated the mechanically-modified fibrin-based tubular constructs as vascular grafts (Grassl et al. 2003). By controlling and balancing between fibrinolysis and cell-produced collagen matrix formation, the modified fibrin can be improved in mechanical strength like ultimate tensile strength or tensile modulus (Grassl et al. 2003). Moreover, cardiomyocytes can be encapsulated using the fibrin material and the strategy influenced cell alignments like cardiac muscle bundles for functioning restoration (Black et al. 2009). In particular, 3-D fibrin architectures could guide cardiac cell alignments and maintained synchronous beating in the in-vitro environment (Huang et al. 2007)
2.3 Musculoskeletal Tissue Engineering
The musculoskeletal complex is the major system to support organs and tissues as well as allow the appropriate movements with structural stabilities. The system has the bone skeleton and fibrous connective tissues. The mineralized tissue or bone in the system plays a critical role to protect the vital organs, provide locomotion of body, and produce blood cells. Moreover, fibrous connective tissues like ligaments, muscles, cartilage, or tendons can contribute the fundamental mobility after integration with bone (ligament, tendon, or cartilage) or muscles (tendon) (Stevens 2008).
In bone constructs, there are two major patterns to generate mechanical responses by remodeling tissues like compact (cortical bone) and trabecular patterns (cancellous bone) (Clarke 2008; Stevens 2008). In particular, the bone remodeling process can be contributed by significant cell activations of osteoblasts for regeneration and osteoclasts for destruction (Stevens 2008) However, if the physiological balance for bone remodeling is lost by diseases or greater defects than osteogenic wound healing, various osteoconductive or osteoinductive materials could be critically considered to promote bone regeneration as well as bone substitutes (Noori et al. 2017; Stevens 2008).
Fibrin matrices fundamentally have numerous proteins and growth factors so, they have widely utilized in bone tissue engineering in various preclinical and clinical scenarios. They can biologically contribute the upregulation of osteoblast expressions and significantly promote bone tissue regeneration (Ben-Ari et al. 2009; Schek et al. 2004; Stevens 2008). Although fibrin has these great biological or biochemical properties, it is challenging to improve and modify rapid biodegradability and poor mechanical properties for skeletal structure neogenesis. Therefore, fibrin-incorporated bioactive composite materials have been developed using inorganic materials to have similar compositions to bone minerals with mechanical strength and enhance osteogenesis or organic materials to enable 3-D fabrications for favorable architectures with biodegradability and characterize biochemical/biological properties (Stevens 2008).
Of fibrous connective tissues in the musculoskeletal system, the cartilage is major structural component of ears, nose, or joint areas with higher stiffness and less flexibility than other fibrous tissues (Lee et al. 2012; Neovius and Kratz 2003; Passaretti et al. 2001; Peretti et al. 2006). In particular, articular cartilage has no vascular structures or nerves so, nutrition can be diffused to chondrocytes and the articular cartilage can particularly be too slowly remolded to have tissue regeneration or repair (Zhang et al. 2009). It is placed on the surface of joints to provide protection and movements of skeletal structures under compressive forces. Because mechanical responses of articular cartilage structures are significantly considered in frictional, compressive, or shear loading environments, cartilage can be demonstrated as resilient and viscoelastic tissue constructs at the skeletal joints (Zhang et al. 2009).
For the cartilage tissue engineering, fibrin material is widely studied and applied for various preclinical studies with clinical implications like chondrocyte-fibrin constructs or injectable fibrin gel containing cells to promote cartilage formations (Eyrich et al. 2007; Horak et al. 2014; Makris et al. 2015; Vinatier et al. 2009). However, environmental specificity of the cartilage construct under biomechanical stimulations can be a challenge for the cartilage regeneration using 3-D fibrin scaffold so, chondrocyte-associated fibrin sealant or fibrin glue have been popularly utilized.
2.4 Nerve Tissue Engineering
Nerve tissue categorizes two major parts like central nervous system (CNS) and peripheral nervous system (PNS) to regulate body functions. It mainly consists of nerve cells (neurons) to transmit impulses and glial cells (neuroglia) to provide nutrients and oxygen to neurons. The CNS has sophisticated dynamic networks with physicochemical communications to exchange sensed information. PNS consists of sensory and motor axons surrounded my myelin sheaths which Schwann cells produced (Johnson et al. 2010, 2013; Schmidt and Leach 2003; Subramanian et al. 2009). In various traumatic injuries or diseased destructions, CNS and PNS have different capacity of regeneration; CNS axons cannot be regenerated but peripheral nerves can be healed by extending new axonal sprouts (Schmidt and Leach 2003).
To guide the directional orientations with new nerve tissue regeneration, various biomaterials have been developed and utilized as the nerve conduits in preclinical and clinical situations (Sakiyama-Elbert and Hubbell 2000; Tsai et al. 2006). In particular, fibrin matrices have been used to fill hollow nerve conduits across the nerve defect regions to promote axonal regeneration and growth (Tsai et al. 2006). Moreover, fibrin scaffolds have been limitedly used for spinal cord regeneration or neural fiber formations at the early stage (Johnson et al. 2010).
3 Technical Applications for Tissue Regeneration in Fibrin Biomaterials
For the strategic applications for tissue engineering using fibrin matrices, various fabrication and modification techniques have been developed and applied for preclinical and clinical scenarios (Table 16.2). In particular, target tissues or injured defect dimensions should be significant considerations to manufacture fibrin products for the appropriate medical or surgical treatments. Commonly, fibrin gel has been widely considered as a sealant or a bioadhesive for hemostasis or wound closure (Mehdizadeh and Yang 2013) because the fibrin shows the minimal inflammation, foreign body reaction, or rapid degradation (Schmidt and Leach 2003).
As target cell or favorable biologic delivery systems, the injectable fibrin gel has been investigated as a carrier: such as cardiomyoblast delivery (Camci-Unal et al. 2014), bone marrow cells (Tajdaran et al. 2015), or bioactive factors (Bensaid et al. 2003; Breen et al. 2009a, b; Tajdaran et al. 2015). Injectable fibrin has been popularly investigated for bone tissue engineering applications because it is not seriously considered for any defect shapes or dimensions and simple invasive implant procedure. To improve the effectiveness and efficacy, it is required to mix the fibrin and biological components like bioactive molecules, cells (or stem cells), or other biomaterials (Li et al. 2015). Moreover, fibrin microbeads are recently studied to deliver a single cell into 3-D engineered micro-environments (or scaffolds) or directly into the injured defect sites for cartilage, cardiac muscle, skin or others (Spicer and Mikos 2010; Tajdaran et al. 2015; Whelan et al. 2014; Yuan Ye et al. 2011). It can be advantageous to more predictably control the quantities of cells or biologics with high efficacies. Fibrin-based micro-bead delivery systems can also encapsulate various stem cells to promote bone regeneration (Liu et al. 2017).
Although the fibrin has various advantages for tissue regeneration like great cell-material interactions, rapid biodegradability could be the limitation to induce appropriate tissue formation with sufficient time (Hubbell 2003; Mano et al. 2007). Therefore, the fibrin material has been modified with chemical agents to control degradability or enhance crosslinking for improvements of biological and mechanical properties (Park et al. 2017; Tallawi et al. 2015). In particular, various cell types can affect fibrin degradation rate because different biologics can be produced by biological interactions between cells and fibrin matrices (Brown and Barker 2014). Recently, Park et al. investigated that the cementoblast and osteoblast generated significantly different matrix metalloproteinases (MMPs) in in-vitro and modified fibrins for slow biodegradation critically contributed to promote cementogenesis and insert/integrate fibrous connective tissues within the mineralized tissues in in-vivo (Park et al. 2017).
For the 3-D scaffolds with geometric or architectural specificities, 3-D additive manufacturing or 3-D printing techniques have been currently highlighted and rapidly developed for biomedical applications (Gu et al. 2016; Lorber et al. 2014; Pati et al. 2015; Rimann et al. 2015; Xu et al. 2006). Of various polymeric materials for 3-D printing systems, the fibrin material is limitedly utilized as the bioink which is the hydrogel material with biological components like cells or biologics for soft tissue engineering (Gu et al. 2016). Xu et al. demonstrated that the 3-D printing fabrication manufactured the fibrin constructs for neural tissue-guiding scaffolds (Xu et al. 2006) and Lee et al. presented the modified fibrin material with murine neural stem cells was used for build the 3-D architectures for nerve tissue formations (Lee et al. 2010).
4 Future Perspectives for Fibrin Biomaterials in Tissue Engineering and Regenerative Medicine
Fibrin has showed the high potential in functioning as an injectable materials, property-controlled materials with cell-material interactions, and 3-D printed scaffolds for tissue engineering and regenerative medicine. However, there are still numerous limitations like the poor mechanical properties for skeletal tissue regeneration, potential disease transmission by unpredictable biological affinities, or deformability of fibrin hydrogels. Many efforts have been contributed to improve the mechanical strength to extend applications with wide spectra and investigate synthetic biopolymeric material composite to characterize as biological or bioactive materials like polyglycolic acid and poly(lactic-co-glycolic acid).
References
Ahmed TA, Dare EV, Hincke M (2008) Fibrin: a versatile scaffold for tissue engineering applications. Tissue Eng Part B Rev 14:199–215
Albala DM, Lawson JH (2006) Recent clinical and investigational applications of fibrin sealant in selected surgical specialties. J Am Coll Surg 202(4):685–697
Andree C, Munder BI, Behrendt P, Hellmann S, Audretsch W, Voigt M et al (2008) Improved safety of autologous breast reconstruction surgery by stabilisation of microsurgical vessel anastomoses using fibrin sealant in 349 free DIEP or fascia-muscle-sparing (fms)-TRAM flaps: a two-centre study. Breast 17(5):492–498
Baron R, Kneissel M (2013) WNT signaling in bone homeostasis and disease: from human mutations to treatments. Nat Med 19(2):179–192
Ben-Ari A, Rivkin R, Frishman M, Gaberman E, Levdansky L, Gorodetsky R (2009) Isolation and implantation of bone marrow-derived mesenchymal stem cells with fibrin micro beads to repair a critical-size bone defect in mice. Tissue Eng A 15(9):2537–2546
Bensaid W, Triffitt JT, Blanchat C, Oudina K, Sedel L, Petite H (2003) A biodegradable fibrin scaffold for mesenchymal stem cell transplantation. Biomaterials 24(14):2497–2502
Black LD 3rd, Meyers JD, Weinbaum JS, Shvelidze YA, Tranquillo RT (2009) Cell-induced alignment augments twitch force in fibrin gel-based engineered myocardium via gap junction modification. Tissue Eng A 15(10):3099–3108
Breen A, O'Brien T, Pandit A (2009a) Fibrin as a delivery system for therapeutic drugs and biomolecules. Tissue Eng Part B Rev 15:201–214
Breen A, O’Brien T, Pandit A (2009b) Fibrin as a delivery system for therapeutic drugs and biomolecules. Tissue Eng Part B Rev 15(2):201–214
Brown AC, Barker TH (2014) Fibrin-based biomaterials: modulation of macroscopic properties through rational design at the molecular level. Acta Biomater 10(4):1502–1514
Buchta C, Hedrich HC, Macher M, Hocker P, Redl H (2005) Biochemical characterization of autologous fibrin sealants produced by CryoSeal and Vivostat in comparison to the homologous fibrin sealant product Tissucol/Tisseel. Biomaterials 26(31):6233–6241
Camci-Unal G, Annabi N, Dokmeci MR, Liao R, Khademhosseini A (2014) Hydrogels for cardiac tissue engineering. NPG Asia Mater 6:e99
Chang WG, Niklason LE (2017) A short discourse on vascular tissue engineering. NPJ Regen Med 2
Chaudhari AA, Vig K, Baganizi DR, Sahu R, Dixit S, Dennis V et al (2016) Future prospects for scaffolding methods and biomaterials in skin tissue engineering: a review. Int J Mol Sci 17(12)
Chernousov MA, Carey DJ (2003) alphaVbeta8 integrin is a Schwann cell receptor for fibrin. Exp Cell Res 291(2):514–524
Clarke B (2008) Normal bone anatomy and physiology. Clin J Am Soc Nephrol 3(Suppl 3):S131–S139
Collet JP, Park D, Lesty C, Soria J, Soria C, Montalescot G et al (2000) Influence of fibrin network conformation and fibrin fiber diameter on fibrinolysis speed: dynamic and structural approaches by confocal microscopy. Arterioscler Thromb Vasc Biol 20:1354–1361
Connelly JT, Vanderploeg EJ, Levenston ME (2004) The influence of cyclic tension amplitude on chondrocyte matrix synthesis: experimental and finite element analyses. Biorheology 41(3–4):377–387
Cummings CL, Gawlitta D, Nerem RM, Stegemann JP (2004) Properties of engineered vascular constructs made from collagen, fibrin, and collagen-fibrin mixtures. Biomaterials 25(17):3699–3706
Davis HE, Miller SL, Case EM, Leach JK (2011) Supplementation of fibrin gels with sodium chloride enhances physical properties and ensuing osteogenic response. Acta Biomater 7:691–699
Eyrich D, Brandl F, Appel B, Wiese H, Maier G, Wenzel M et al (2007) Long-term stable fibrin gels for cartilage engineering. Biomaterials 28(1):55–65
Falanga V, Iwamoto S, Chartier M, Yufit T, Butmarc J, Kouttab N et al (2007) Autologous bone marrow-derived cultured mesenchymal stem cells delivered in a fibrin spray accelerate healing in murine and human cutaneous wounds. Tissue Eng 13:1299–1312
Flanagan TC, Cornelissen C, Koch S, Tschoeke B, Sachweh JS, Schmitz-Rode T et al (2007) The in vitro development of autologous fibrin-based tissue-engineered heart valves through optimised dynamic conditioning. Biomaterials 28(23):3388–3397
Gebara MM, Sayre MH, Corden JL (1997) Phosphorylation of the carboxy-terminal repeat domain in RNA polymerase II by cyclin-dependent kinases is sufficient to inhibit transcription. J Cell Biochem 64(3):390–402
Grassl ED, Oegema TR, Tranquillo RT (2003) A fibrin-based arterial media equivalent. J Biomed Mater Res A 66(3):550–561
Gu BK, Choi DJ, Park SJ, Kim MS, Kang CM, Kim CH (2016) 3-dimensional bioprinting for tissue engineering applications. Biomater Res 20(12):12
Hall H (2007) Modified fibrin hydrogel matrices: both, 3D-scaffolds and local and controlled release systems to stimulate angiogenesis. Curr Pharm Des 13(35):3597–3607
Hall H, Hubbell JA (2004) Matrix-bound sixth Ig-like domain of cell adhesion molecule L1 acts as an angiogenic factor by ligating alphavbeta3-integrin and activating VEGF-R2. Microvasc Res 68(3):169–178
Hall H, Djonov V, Ehrbar M, Hoechli M, Hubbell JA (2004) Heterophilic interactions between cell adhesion molecule L1 and alphavbeta3-integrin induce HUVEC process extension in vitro and angiogenesis in vivo. Angiogenesis 7(3):213–223
Hasan A, Khattab A, Islam MA, Hweij KA, Zeitouny J, Waters R et al (2015) Injectable hydrogels for cardiac tissue repair after myocardial infarction. Adv Sci 2(11):1500122
Herbert CB, Nagaswami C, Bittner GD, Hubbell JA, Weisel JW (1998) Effects of fibrin micromorphology on neurite growth from dorsal root ganglia cultured in three-dimensional fibrin gels. J Biomed Mater Res 40(4):551–559
Horak M, Handl M, Podskubka A, Kana R, Adler J, Povysil C (2014) Comparison of the cellular composition of two different chondrocyte-seeded biomaterials and the results of their transplantation in humans. Folia Biol 60(1):1–9
Huang S, Fu X (2010) Naturally derived materials-based cell and drug delivery systems in skin regeneration. J Control Release 142(2):149–159
Huang YC, Khait L, Birla RK (2007) Contractile three-dimensional bioengineered heart muscle for myocardial regeneration. J Biomed Mater Res A 80((3):719–731
Hubbell JA (2003) Materials as morphogenetic guides in tissue engineering. Curr Opin Biotechnol 14(5):551–558
Janmey PA, Winer JP, Weisel JW (2009) Fibrin gels and their clinical and bioengineering applications. J R Soc Interface 6(30):1–10
Jimenez PA, Jimenez SE (2004) Tissue and cellular approaches to wound repair. Am J Surg 187(5A):56S–64S
Johnson PJ, Parker SR, Sakiyama-Elbert SE (2010) Fibrin-based tissue engineering scaffolds enhance neural fiber sprouting and delay the accumulation of reactive astrocytes at the lesion in a subacute model of spinal cord injury. J Biomed Mater Res A 92((1):152–163
Johnson PJ, Wood MD, Moore AM, Mackinnon SE (2013) Tissue engineered constructs for peripheral nerve surgery. Eur Surg 45(3). https://doi.org/10.1007/s10353-013-0205-0
Koob S, Torio-Padron N, Stark GB, Hannig C, Stankovic Z, Finkenzeller G (2011) Bone formation and neovascularization mediated by mesenchymal stem cells and endothelial cells in critical-sized calvarial defects. Tissue Eng A 17(3–4):311–321
Laurens N, Koolwijk P, de Maat MP (2006a) Fibrin structure and wound healing. J Thromb Haemost 4:932–939
Laurens N, Koolwijk P, de Maat MP (2006b) Fibrin structure and wound healing. J Thromb Haemost 4(5):932–939
Lee F, Kurisawa M (2013) Formation and stability of interpenetrating polymer network hydrogels consisting of fibrin and hyaluronic acid for tissue engineering. Acta Biomater 9(2):5143–5152
Lee KY, Mooney DJ (2001) Hydrogels for tissue engineering. Chem Rev 101(7):1869–1879
Lee YB, Polio S, Lee W, Dai G, Menon L, Carroll RS et al (2010) Bio-printing of collagen and VEGF-releasing fibrin gel scaffolds for neural stem cell culture. Exp Neurol 223(2):645–652
Lee JC, Lee SY, Min HJ, Han SA, Jang J, Lee S et al (2012) Synovium-derived mesenchymal stem cells encapsulated in a novel injectable gel can repair osteochondral defects in a rabbit model. Tissue Eng A 18(19–20):2173–2186
Li Y, Meng H, Liu Y, Lee BP (2015) Fibrin gel as an injectable biodegradable scaffold and cell carrier for tissue engineering. TheScientificWorldJOURNAL 2015(685690):1
Liu M, Zeng X, Ma C, Yi H, Ali Z, Mou X et al (2017) Injectable hydrogels for cartilage and bone tissue engineering. Bone Res 5:17014
Lorber B, Hsiao WK, Hutchings IM, Martin KR (2014) Adult rat retinal ganglion cells and glia can be printed by piezoelectric inkjet printing. Biofabrication 6(1):015001
MacNeil S (2008) Biomaterials for tissue engineering of skin. Mater Today 11(5):26–35
Makogonenko E, Tsurupa G, Ingham K, Medved L (2002) Interaction of fibrin(ogen) with fibronectin: further characterization and localization of the fibronectin-binding site. Biochemistry 41:7907–7913
Makris EA, Gomoll AH, Malizos KN, Hu JC, Athanasiou KA (2015) Repair and tissue engineering techniques for articular cartilage. Nat Rev Rheumatol 11(1):21–34
Mano JF, Silva GA, Azevedo HS, Malafaya PB, Sousa RA, Silva SS et al (2007) Natural origin biodegradable systems in tissue engineering and regenerative medicine: present status and some moving trends. J R Soc Interface 4(17):999–1030
Mehdizadeh M, Yang J (2013) Design strategies and applications of tissue bioadhesives. Macromol Biosci 13(3):271–288
Molly L, Quirynen M, Michiels K, van Steenberghe D (2006) Comparison between jaw bone augmentation by means of a stiff occlusive titanium membrane or an autologous hip graft: a retrospective clinical assessment. Clin Oral Implants Res 17(5):481–487
Mosesson MW (2005) Fibrinogen and fibrin structure and functions. J Thromb Haemost 3:1894–1904
Neovius EB, Kratz G (2003) Tissue engineering by cocultivating human elastic chondrocytes and keratinocytes. Tissue Eng 9(2):365–369
Noori A, Ashrafi SJ, Vaez-Ghaemi R, Hatamian-Zaremi A, Webster TJ (2017) A review of fibrin and fibrin composites for bone tissue engineering. Int J Nanomedicine 12:4937–4961
Oh JH, Kim HJ, Kim TI, Baek JH, Ryoo HM, Woo KM (2012) The effects of the modulation of the fibronectin-binding capacity of fibrin by thrombin on osteoblast differentiation. Biomaterials 33:4089–4099
Oh JH, Kim HJ, Kim TI, Woo KM (2014) Comparative evaluation of the biological properties of fibrin for bone regeneration. BMB Rep 47(2):110–114
Park CH, Oh JH, Jung HM, Choi Y, Rahman SU, Kim S et al (2017) Effects of the incorporation of epsilon-aminocaproic acid/chitosan particles to fibrin on cementoblast differentiation and cementum regeneration. Acta Biomater 61:134–143
Passaretti D, Silverman RP, Huang W, Kirchhoff CH, Ashiku S, Randolph MA et al (2001) Cultured chondrocytes produce injectable tissue-engineered cartilage in hydrogel polymer. Tissue Eng 7(6):805–815
Pati F, Ha DH, Jang J, Han HH, Rhie JW, Cho DW (2015) Biomimetic 3D tissue printing for soft tissue regeneration. Biomaterials 62(164–175
Peretti GM, Xu JW, Bonassar LJ, Kirchhoff CH, Yaremchuk MJ, Randolph MA (2006) Review of injectable cartilage engineering using fibrin gel in mice and swine models. Tissue Eng 12(5):1151–1168
Perka C, Schultz O, Spitzer RS, Lindenhayn K, Burmester GR, Sittinger M (2000) Segmental bone repair by tissue-engineered periosteal cell transplants with bioresorbable fleece and fibrin scaffolds in rabbits. Biomaterials 21(11):1145–1153
Pober JS, Tellides G (2012) Participation of blood vessel cells in human adaptive immune responses. Trends Immunol 33(1):49–57
Priya SG, Jungvid H, Kumar A (2008) Skin tissue engineering for tissue repair and regeneration. Tissue Eng Part B Rev 14(1):105–118
Rimann M, Laternser S, Keller H, Leupin O, Graf-Hausner U (2015) 3D bioprinted muscle and tendon tissues for drug development. Chimia 69(1–2):65–67
Rybarczyk BJ, Lawrence SO, Simpson-Haidaris PJ (2003) Matrix-fibrinogen enhances wound closure by increasing both cell proliferation and migration. Blood 102:4035–4043
Sacchi V, Mittermayr R, Hartinger J, Martino MM, Lorentz KM, Wolbank S et al (2014) Long-lasting fibrin matrices ensure stable and functional angiogenesis by highly tunable, sustained delivery of recombinant VEGF164. Proc Natl Acad Sci USA 111(19):6952–6957
Sakiyama SE, Schense JC, Hubbell JA (1999) Incorporation of heparin-binding peptides into fibrin gels enhances neurite extension: an example of designer matrices in tissue engineering. FASEB J 13(15):2214–2224
Sakiyama-Elbert SE, Hubbell JA (2000) Development of fibrin derivatives for controlled release of heparin-binding growth factors. J Control Release 65(3):389–402
Saltz R, Sierra D, Feldman D, Saltz MB, Dimick A, Vasconez LO (1991) Experimental and clinical applications of fibrin glue. Plast Reconstr Surg 88(6):1005–1015 discussion 1016-1007
Santoro E, Agresta F, Buscaglia F, Mulieri G, Mazzarolo G, Bedin N et al (2007) Preliminary experience using fibrin glue for mesh fixation in 250 patients undergoing minilaparoscopic transabdominal preperitoneal hernia repair. J Laparoendosc Adv Surg Tech A 17(1):12–15
Schek RM, Hollister SJ, Krebsbach PH (2004) Delivery and protection of adenoviruses using biocompatible hydrogels for localized gene therapy. Mol Ther 9(1):130–138
Schmidt CE, Leach JB (2003) Neural tissue engineering: strategies for repair and regeneration. Annu Rev Biomed Eng 5:293–347
Simonpieri A, Del Corso M, Vervelle A, Jimbo R, Inchingolo F, Sammartino G et al (2012) Current knowledge and perspectives for the use of platelet-rich plasma (PRP) and platelet-rich fibrin (PRF) in oral and maxillofacial surgery part 2: bone graft, implant and reconstructive surgery. Curr Pharm Biotechnol 13(7):1231–1256
Spicer PP, Mikos AG (2010) Fibrin glue as a drug delivery system. J Control Release 148(1):49–55
Stevens MM (2008) Biomaterials for bone tissue engineering. Mater Today 11(5):18–25
Subramanian A, Krishnan UM, Sethuraman S (2009) Development of biomaterial scaffold for nerve tissue engineering: biomaterial mediated neural regeneration. J Biomed Sci 16:108
Tajdaran K, Shoichet MS, Gordon T, Borschel GH (2015) A novel polymeric drug delivery system for localized and sustained release of tacrolimus (FK506). Biotechnol Bioeng 112(9):1948–1953
Tallawi M, Rosellini E, Barbani N, Cascone MG, Rai R, Saint-Pierre G et al (2015) Strategies for the chemical and biological functionalization of scaffolds for cardiac tissue engineering: a review. J R Soc Interface 12(108):20150254
Tsai EC, Dalton PD, Shoichet MS, Tator CH (2006) Matrix inclusion within synthetic hydrogel guidance channels improves specific supraspinal and local axonal regeneration after complete spinal cord transection. Biomaterials 27(3):519–533
Vinatier C, Bouffi C, Merceron C, Gordeladze J, Brondello JM, Jorgensen C et al (2009) Cartilage tissue engineering: towards a biomaterial-assisted mesenchymal stem cell therapy. Curr Stem Cell Res Ther 4(4):318–329
Wechselberger G, Russell RC, Neumeister MW, Schoeller T, Piza-Katzer H, Rainer C (2002) Successful transplantation of three tissue-engineered cell types using capsule induction technique and fibrin glue as a delivery vehicle. Plast Reconstr Surg 110(1):123–129
Westreich R, Kaufman M, Gannon P, Lawson W (2004) Validating the subcutaneous model of injectable autologous cartilage using a fibrin glue scaffold. Laryngoscope 114(12):2154–2160
Whelan D, Caplice NM, Clover AJ (2014) Fibrin as a delivery system in wound healing tissue engineering applications. J Control Release 196:1–8
Wolberg AS (2007) Thrombin generation and fibrin clot structure. Blood Rev 21:131–142
Xu T, Gregory CA, Molnar P, Cui X, Jalota S, Bhaduri SB et al (2006) Viability and electrophysiology of neural cell structures generated by the inkjet printing method. Biomaterials 27(19):3580–3588
Ye Q, Zund G, Benedikt P, Jockenhoevel S, Hoerstrup SP, Sakyama S et al (2000) Fibrin gel as a three dimensional matrix in cardiovascular tissue engineering. Eur J Cardiothoracic Surg 17(5):587–591
Yuan Ye K, Sullivan KE, Black LD (2011) Encapsulation of cardiomyocytes in a fibrin hydrogel for cardiac tissue engineering. J Vis Exp 55
Zhang L, Hu J, Athanasiou KA (2009) The role of tissue engineering in articular cartilage repair and regeneration. Crit Rev Biomed Eng 37(1–2):1–57
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Park, C.H., Woo, K.M. (2018). Fibrin-Based Biomaterial Applications in Tissue Engineering and Regenerative Medicine. In: Noh, I. (eds) Biomimetic Medical Materials. Advances in Experimental Medicine and Biology, vol 1064. Springer, Singapore. https://doi.org/10.1007/978-981-13-0445-3_16
Download citation
DOI: https://doi.org/10.1007/978-981-13-0445-3_16
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-13-0444-6
Online ISBN: 978-981-13-0445-3
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)